Varex Imaging (NASDAQ:VREX – Get Free Report) updated its third quarter 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.150-0.300 for the period, compared to the consensus estimate of 0.220. The company issued revenue guidance of $210.0 million-$225.0 million, compared to the consensus revenue estimate of $215.5 million.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on the company. Zacks Research upgraded Varex Imaging from a “hold” rating to a “strong-buy” rating in a research report on Monday, April 13th. Jefferies Financial Group restated a “hold” rating and set a $14.50 price target on shares of Varex Imaging in a research report on Monday, February 2nd. Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a research report on Friday, March 27th. B. Riley Financial restated a “buy” rating on shares of Varex Imaging in a research report on Thursday, February 12th. Finally, Wall Street Zen downgraded Varex Imaging from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 25th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Varex Imaging has a consensus rating of “Moderate Buy” and a consensus target price of $16.17.
Varex Imaging Trading Down 2.8%
Varex Imaging (NASDAQ:VREX – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). Varex Imaging had a negative net margin of 7.92% and a positive return on equity of 8.43%. The firm had revenue of $216.00 million for the quarter, compared to the consensus estimate of $216.92 million. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. As a group, sell-side analysts predict that Varex Imaging will post 0.93 EPS for the current year.
Insider Transactions at Varex Imaging
In related news, Director Jay K. Kunkel sold 4,510 shares of the business’s stock in a transaction dated Friday, March 20th. The stock was sold at an average price of $11.14, for a total transaction of $50,241.40. Following the transaction, the director owned 23,450 shares in the company, valued at $261,233. The trade was a 16.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.60% of the stock is currently owned by corporate insiders.
Institutional Trading of Varex Imaging
Large investors have recently bought and sold shares of the company. Quarry LP bought a new stake in Varex Imaging during the 3rd quarter valued at approximately $64,000. BNP Paribas Financial Markets boosted its position in Varex Imaging by 18.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after acquiring an additional 2,036 shares in the last quarter. Aquatic Capital Management LLC bought a new stake in Varex Imaging during the 3rd quarter valued at approximately $117,000. Cerity Partners LLC bought a new stake in Varex Imaging during the 2nd quarter valued at approximately $123,000. Finally, The Manufacturers Life Insurance Company boosted its position in Varex Imaging by 10.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock valued at $133,000 after acquiring an additional 1,442 shares in the last quarter.
About Varex Imaging
Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.
The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.
Read More
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
